logo image
search icon
Integrated Drug Containment And Delivery Solutions Market

Integrated Drug Containment And Delivery Solutions Market Size, Share & Trends Analysis Report By Product (Pre-Fillable Syringes, Auto-Injectors And Inhalers, Nasal Sprays, Transdermal Patches), Packaging (Vials, Ampoules, Bottles, And Blisters) And End Users (Hospitals, Clinics, Home Care Settings And Ambulatory Surgical Centers), Region And Segment Forecasts, 2023-2031

Report ID : 1823 | Published : 2023-05-25 | Pages: 180 | Format: PDF/EXCEL

The Global Integrated Drug Containment And Delivery Solutions Market Size is predicted to witness a 11.87% CAGR during the forecast period for 2023-2031.

The market is projected to grow substantially due to the growing prevalence of chronic illnesses and the increasing demand for injectable medications. The increased emphasis on patient safety and the rising demand for creative medication delivery systems are projected to expand the integrated drug containment and delivery solutions market. The need for user-friendly drug storage and delivery systems that reduce the likelihood of medication errors is growing.

Integrated Drug Containment And Delivery Solutions Market

Additionally, the market is anticipated to increase due to the rising use of prefilled syringes and other cutting-edge medication delivery technologies. The increasing incidences of chronic conditions like cancer, diabetes, and heart disease drive the market.  Furthermore, the increasing use of self-administered injectable drugs has also contributed to the market's expansion. The expensive cost of creating and deploying these systems passed on to the end users may be a major impediment to the uptake of these solutions. The market's expansion may need to be improved by end users' need to gain knowledge of these systems' advantages, particularly in emerging markets. 

Recent Developments:

  • In June 2020-Aptar Pharma revealed that they had partnered with Eli Lilly and Company to create an inhaler that could potentially be granted (EUA) for treating COVID-19.
  • In October 2019, Hergesheimer AG announced that it had formed a collaboration with Sensile Medical AG to develop and produce a wearable drug delivery apparatus for diabetes treatment. 

Competitive Landscape:

Some of the Integrated Drug Containment and Delivery Solutions market players are:

  • BD (Becton, Dickinson, and Company)
  • Hergesheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • AptarGroup, Inc.
  • Catalent, Inc.
  • Stearate Group
  • NIPRO
  • Owen Mumford Limited
  • Psalmed AG 

Market Segmentation:

The integrated drug containment and delivery solutions market is segmented based on product, packaging and end users. By product type, the integrated drug containment and delivery solutions market is categorized into pre-fillable syringes, auto-injectors and inhalers. The market is segmented as vials, ampoules, bottles, and blisters based on packaging. By end users, the integrated drug containment and delivery solutions market is segmented into hospitals, clinics, Home Care Settings and ambulatory surgical centers.

Based On Product, The Prefilled Syringes Segment Is A Major Contributor To The Integrated Drug Containment And Delivery Solutions Market

The prefilled syringes will hold a major share in the global integrated drug containment and delivery solutions market in 2022. Prefilled syringes are increasingly being used in hospitals, clinics, and home healthcare settings due to their ease of use, accuracy of dose, and reduced risk of contamination. Moreover, prefilled syringes are suitable for various drugs, including biologics, vaccines, and biosimilars. Using prefilled syringes is also beneficial for drug manufacturers, as they can help reduce drug waste, improve product stability, and increase manufacturing efficiency.

The Hospital's Segment Witnessed Growth At A Rapid Rate

The hospital segment is projected to grow rapidly in the global integrated drug containment and delivery solutions market. Hospitals are significant consumers of integrated drug containment and delivery solutions, as they require safe and effective drug delivery systems to administer medications to their patients. Advanced drug delivery systems, such as prefilled syringes and wearable drug delivery devices, are becoming increasingly popular in hospitals because they provide targeted and sustained release of medications, improving patient outcomes and compliance. Adopting self-administered injectable drugs and home healthcare services also contributes to the growth of hospitals' integrated drug containment and delivery solutions market.

The North America Integrated Drug Containment And Delivery Solutions Market Holds A Significant Regional Revenue Share

The North American region is expected to develop the highest market share due to the region's rising prevalence of chronic diseases and the developing use of cutting-edge drug delivery technologies in healthcare facilities. In light of the increased prevalence of chronic diseases, the adoption of self-administered drug delivery devices, and the demand for sophisticated drug delivery systems, it is predicted that the market for integrated drug containment and delivery solutions will grow significantly throughout the forecast period. Furthermore, the Asia Pacific regional market is projected to hold the second-largest share. The necessity for advanced drug delivery systems is expanding in emerging economies like China and India. This explains the existence of significant market participants and the growing collaboration among major firms for market penetration in the region.

Integrated Drug Containment And Delivery Solutions Market Report Scope:

Report Attribute

Specifications

Growth rate CAGR

CAGR of 36.75% from 2023 to 2031

Quantitative units

Representation of revenue in US$ Billion, and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Product, Packaging And End Users

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

BD (Becton, Dickinson, and Company), Gerresheimer AG, West Pharmaceutical Services, Inc., Schott AG, AptarGroup, Inc., Catalent, Inc., Stevanato Group, NIPRO, Owen Mumford Limited and Ypsomed AG.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Integrated Drug Containment and Delivery Solutions Market Snapshot

Chapter 4. Global Integrated Drug Containment and Delivery Solutions Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Pre-fillable syringes
5.2.2. Auto-injectors
5.2.3. Inhalers
5.2.4. Nasal Sprays
5.2.5. Transdermal Patches
5.2.6. Others

Chapter 6. Market Segmentation 2: by Packaging Type Estimates & Trend Analysis
6.1. by Packaging Type & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Packaging Type:

6.2.1. Vials
6.2.2. Ampoules
6.2.3. Cartridges
6.2.4. Bottles
6.2.5. Blisters

Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:

7.2.1. Clinics
7.2.2. Ambulatory Surgical Centers
7.2.3. Home Care Settings

Chapter 8. Integrated Drug Containment and Delivery Solutions Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.1.2. North America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Packaging Type, 2023-2031
8.1.3. North America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.1.4. North America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.2. Europe

8.2.1. Europe Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.2.2. Europe Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Packaging Type, 2023-2031
8.2.3. Europe Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.2.4. Europe Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.3.2. Asia Pacific Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Packaging Type, 2023-2031
8.3.3. Asia-Pacific Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.3.4. Asia Pacific Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.4. Latin America

8.4.1. Latin America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.4.2. Latin America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Packaging Type, 2023-2031
8.4.3. Latin America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.4.4. Latin America Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
8.5.2. Middle East & Africa Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by Packaging Type, 2023-2031
8.5.3. Middle East & Africa Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2023-2031
8.5.4. Middle East & Africa Integrated Drug Containment and Delivery Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles


9.2.1. BD (Becton, Dickinson, and Company)
9.2.2. Hergesheimer AG
9.2.3. West Pharmaceutical Services, Inc.
9.2.4. Schott AG
9.2.5. AptarGroup, Inc.
9.2.6. Catalent, Inc.
9.2.7. Stearate Group
9.2.8. NIPRO
9.2.9. Owen Mumford Limited
9.2.10. Psalmed AG
9.2.11. Other Prominent Players

Segmentation of Integrated Drug Containment and Delivery Solutions Market:

Integrated Drug Containment and Delivery Solutions Market By Product-

  • Pre-Fillable Syringe
  • Auto-Injectors
  • Inhalers
  • Nasal Sprays
  • Transdermal Patches
  • Others

Integrated Drug Containment And Delivery Solutions Market

Integrated Drug Containment and Delivery Solutions Market By Packaging-

  • Vials
  • Ampoules
  • Cartridges
  • Bottles
  • Blisters

Integrated Drug Containment and Delivery Solutions Market By End Users

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Integrated Drug Containment And Delivery Solutions Market?

Integrated Drug Containment And Delivery Solutions Market expected to grow at a 11.87% CAGR during the forecast period for 2023-2031

BD (Becton, Dickinson, and Company), Gerresheimer AG, West Pharmaceutical Services, Inc., Schott AG, AptarGroup, Inc., Catalent, Inc., Stevanato Group

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach